Federation des caisses Desjardins du Quebec’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.8M | Sell |
16,907
-25,301
| -60% | -$6.31M | 0.01% | 536 |
|
|
2025
Q4 | $10.2M | Sell |
42,208
-33,316
| -44% | -$8.52M | 0.04% | 279 |
|
|
2025
Q3 | $20.7M | Sell |
75,524
-2,552
| -3% | -$697K | 0.08% | 179 |
|
|
2025
Q2 | $20.1M | Sell |
78,076
-228
| -0.3% | -$54.4K | 0.09% | 170 |
|
|
2025
Q1 | $17.5M | Buy |
78,304
+1,431
| +2% | +$334K | 0.09% | 161 |
|
|
2024
Q4 | $17.6M | Sell |
76,873
-684
| -0.9% | -$165K | 0.09% | 166 |
|
|
2024
Q3 | $18.9M | Sell |
77,557
-409
| -0.5% | -$91.4K | 0.09% | 155 |
|
|
2024
Q2 | $14.9M | Buy |
77,966
+1,208
| +2% | +$245K | 0.08% | 179 |
|
|
2024
Q1 | $15.2M | Buy |
76,758
+9,049
| +13% | +$1.66M | 0.11% | 163 |
|
|
2023
Q4 | $11.6M | Sell |
67,709
-9,176
| -12% | -$1.41M | 0.11% | 170 |
|
|
2023
Q3 | $11.4M | Sell |
76,885
-436
| -0.6% | -$78.8K | 0.12% | 166 |
|
|
2023
Q2 | $16.9M | Buy |
77,321
+76,690
| +12,154% | +$17.1M | 0.17% | 128 |
|
|
2023
Q1 | $138K | Sell |
631
-1,169
| -65% | -$254K | ﹤0.01% | 1063 |
|
|
2022
Q4 | $375K | Sell |
1,800
-34
| -2% | -$7.47K | ﹤0.01% | 836 |
|
|
2022
Q3 | $400K | Sell |
1,834
-225
| -11% | -$51.2K | ﹤0.01% | 845 |
|
|
2022
Q2 | $432K | Buy |
2,059
+287
| +16% | +$61.1K | ﹤0.01% | 835 |
|
|
2022
Q1 | $430K | Sell |
1,772
-34
| -2% | -$8.22K | ﹤0.01% | 891 |
|
|
2021
Q4 | $470K | Sell |
1,806
-20,866
| -92% | -$5.41M | ﹤0.01% | 871 |
|
|
2021
Q3 | $5.97M | Sell |
22,672
-3,151
| -12% | -$862K | 0.06% | 245 |
|
|
2021
Q2 | $6.36M | Sell |
25,823
-465
| -2% | -$97.8K | 0.06% | 238 |
|
|
2021
Q1 | $5.1M | Sell |
26,288
-64,047
| -71% | -$12.8M | 0.06% | 260 |
|
|
2020
Q4 | $19.2M | Sell |
90,335
-687
| -0.8% | -$137K | 0.23% | 90 |
|
|
2020
Q3 | $15.6M | Sell |
91,022
-17,603
| -16% | -$3.25M | 0.22% | 94 |
|
|
2020
Q2 | $20.9M | Buy |
108,625
+48,863
| +82% | +$7.99M | 0.31% | 73 |
|
|
2020
Q1 | $8.91M | Buy |
59,762
+2,881
| +5% | +$459K | 0.16% | 117 |
|
|
2019
Q4 | $8.81M | Sell |
56,881
-583
| -1% | -$84K | 0.12% | 136 |
|
|
2019
Q3 | $7.77M | Sell |
57,464
-122
| -0.2% | -$16K | 0.11% | 154 |
|
|
2019
Q2 | $7.01M | Buy |
57,586
+2,768
| +5% | +$307K | 0.1% | 172 |
|
|
2019
Q1 | $5.7M | Buy |
54,818
+159
| +0.3% | +$16.4K | 0.09% | 194 |
|
|
2018
Q4 | $6.23M | Buy |
54,659
+67
| +0.1% | +$7.18K | 0.11% | 182 |
|
|
2018
Q3 | $6.3M | Sell |
54,592
-2,744
| -5% | -$301K | 0.09% | 191 |
|
|
2018
Q2 | $5.95M | Sell |
57,336
-3,764
| -6% | -$381K | 0.09% | 208 |
|
|
2018
Q1 | $6.02M | Hold |
61,100
| – | – | 0.09% | 198 |
|
|
2017
Q4 | $5.16M | Sell |
61,100
-75
| -0.1% | -$6.2K | 0.08% | 211 |
|
|
2017
Q3 | $4.72M | Sell |
61,175
-225
| -0.4% | -$17.2K | 0.07% | 223 |
|
|
2017
Q2 | $4.78M | Sell |
61,400
-4,796
| -7% | -$343K | 0.08% | 220 |
|
|
2017
Q1 | $4.76M | Buy |
+66,196
| New | +$4.57M | 0.09% | 196 |
|
Other funds holding RMD
VCM
VPM
DAM
Federation des caisses Desjardins du Quebec's RMD Position: Q1 2026 in Review
Federation des caisses Desjardins du Quebec reduced its ResMed (RMD) stake by 60% in Q1 2026, selling an estimated $6.31M and leaving 16,907 shares worth $3.8M. The position accounts for 0.01% of the portfolio, ranked #536.
Federation des caisses Desjardins du Quebec first reported a position in RMD in Q1 2017 and has held it in 37 quarters since. The position peaked at $20.9M in Q2 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Federation des caisses Desjardins du Quebec held 16,907 shares of ResMed worth $3.8M as of Q1 2026.
- Federation des caisses Desjardins du Quebec sold 25,301 ResMed shares in Q1 2026, an estimated $6.31M.
- ResMed made up 0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #536 holding.
- Federation des caisses Desjardins du Quebec first reported a position in ResMed in Q1 2017 and has held it in 37 quarters since.
- Federation des caisses Desjardins du Quebec's ResMed position peaked at $20.9M in Q2 2020.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.